核心领导团队

QPS的核心领导团队(SLT)共同负责确保QPS的全球运营取得成功。 该团队包含全球各业务职能部门和全球各业务点的代表，主要职责包括进行独立客观的判断，以及向当地管理团队分配具有建设性、挑战性的工作，以确保实现最高水平的绩效。

此外，该团队还负责制定战略和政策，以及监控我们实现年度目标的进度。 我们的首席执行官Ben Chien博士负责领导SLT，担任董事会的主要联系人，并对全球业务的年度绩效负责。 同时，Chien博士还领导SLT团队进行定期业务绩效评估，考察团队的战略思维能力，以敦促团队改善业务结果。

Ben Chien, Ph.D.

Chairman, President and Chief Executive Officer

Ben Hsu, Ph.D. MBA

Chief Administrative Officer and General Manager, QPS LLC

Brendon Bourg

VP, General Manager, Missouri

Camille Picq, MBA

Senior Director,
Head of Lab Services Business Development, Europe

Charlene Chen

Deputy General Manager and Head of CTPS, QPS Taiwan

ChauHwei Fu, Ph.D.

VP, Global Head of Clinical Research Services

Dawn Moore

Executive Director,
Head of Lab Services Business Development, US

Edwin van Vulpen

Executive Director and Head of Clinical Business Development Europe

Gabrielle Pastore

VP, Global Head of Marketing

John Kolman, Ph.D.

VP, Global Head, Translational Medicine

John Musante, MBA

EVP & Head of Global Clinical Services

Jose L. Marcos, CCRC, MT

Executive Director, Clinical Operations

Judy Morris

Director & Head of Global HR

Kevin Vernarec

Sr. VP, Global Head of Late Phase Clinical Development

Kimberley Buytaert-Hoefen, Ph.D.

Executive Director and Global Head of Regulatory Affairs

Kumar Ramu, Ph.D.

Sr. VP, General Manager, India

Manuela Prokesch, Ph.D.

Director of Neuropharmacology

Pedro Gonzalez

VP of Finance

Robert Wronski, Ph.D.

Sr. Director, Head of EU Late Phase Clinical Development

Sarah Cross, Ph.D.

Executive Director & Head of Global Medical Affairs

Vincent Yen, MBA

Regional General Manager, Asia

Wendy Finan

Director, Global Head of Quality Assurance

Wim Tamminga, Ph.D.

Sr. VP, Global Head of Early Phase Clinical

Zamas Lam, Ph.D.

Sr. VP, Global Head, Bioanalytical and Global Head, Preclinical Development

QPS的业务开发团队共同负责与客户建立牢固关系，并为QPS创造业务机会。

该团队向客户分享关于QPS在生物分析、临床研究服务、真皮和透皮研究、DMPK、神经药理学、转化医学、毒理学以及早期和晚期临床试验方面的全球信息。 该团队跨全球各业务职能部门和全球各业务点进行精心部署和协调，旨在理解各个客户的特定需求，并根据具体需求提供定制化研究服务方案。

业务开发团队的职责具体分配给两个团队，均由业界资深人士带领，分别是高级副总裁兼临床前业务开发全球总监Zamas Lam博士和高级副总裁兼临床业务开发全球总监John Musante。 请随时发送电子邮件 [email protected]联系QPS业务开发团队，或在即将举行的会议上与我们沟通交流。 我们期待有机会为您定制新的临床研究解决方案。

临床前业务开发

Camille Picq, MBA

Senior Director,
Head of Lab Services Business Development, Europe

Dawn Moore

Executive Director,
Head of Lab Services Business Development, US

John Katiforis

Director

Joy Concepcion

Director

Mark Warren

Director

早期和后期临床业务开发

John Musante, MBA

EVP & Head of Global Clinical Services

Edwin van Vulpen

Executive Director and Head of Clinical Business Development Europe

Andrew Nehls, MS

Sr. Director

Benjamin Abrams

Director

Darlene Colon, MBA

Director

Jim Cunningham

Executive Director

Jonathan Quinn

Director

Mark McDonald

Sr. Director

Maria Lundius

Director

Robert Cathell

Associate Director, Clinical Business Development

全球业务开发

Alex Chang

VP, Sales and Marketing, Asia

Andrew Lin

Sr. Manager, Taiwan

Bhavya Latha Thirunagari

Manager, India

Chen Huang

Director, Taiwan

Doris Chi

Sr. Manager, China

Ewald Auer, MSc.

Director, Neuropharmacology

Joelle Kasbo

Sr. Director

Matisse Liu

Manager, NKSP, Taiwan

Nick Vrentzos M.Sc.

Sr. Director, India

Roland Rabl

Manager, Neuropharmacology

Stefanie Krassnig, Ph.D.

Manager, Neuropharmacology

Tracy Tsai

Assistant Manager, Taiwan

Vera Niederkofler, Ph.D.

Manager, Neuropharmacology

V.V.S Shiva Prasad, Ph.D.

Chief Operating Officer, India

QPS的主要研究者团队由专职医生组成，并由广泛的补充性专科医生网络支持，可确保从早期研究规划阶段到研究完成始终维持高水平的研究监督。 美国、欧洲、台湾和印度的每个QPS临床试验中心都配有一支专 医生团队，负责确保所有临床试验无缝运行。 这支经验丰富的团队会在临床试验全程与申办者定期沟通。 我们认为，与申办者密切合作将造就最高效、成功的试验。

QPS主要研究者团队的核心职责涵盖全部临床试验活动，从早期方案开发，到研究设计，乃至最终的健康志愿者和/或患者看护。